Literature DB >> 2834392

Ligand-dependent intersubunit association within the insulin receptor complex activates its intrinsic kinase activity.

M Böni-Schnetzler1, A Kaligian, R DelVecchio, P F Pilch.   

Abstract

Insulin receptor halves (alpha beta) were obtained upon selective reduction of the holoreceptor (alpha 2 beta 2) and were isolated in concentrated form. Autophosphorylation of concentrated alpha beta receptor halves can be stimulated by insulin an average of 4.0-fold, whereas nonreduced holoreceptor can be stimulated 5.4-fold. If alpha beta half-receptors are immobilized on wheat germ agglutinin-agarose, no insulin-stimulated autophosphorylation is observed, whereas immobilized holoreceptor retains insulin responsiveness. Treatment of alpha beta half-receptors with glutathione in the presence of insulin results in reoxidation to the holoreceptor form (alpha 2 beta 2) with an efficiency of 60-70% as visualized by immunoblotting, thus providing evidence that two alpha beta halves are in close physical proximity. This reoxidation reaction, which is evident prior to autophosphorylation, is rapid and strictly dependent on the presence of insulin, consistent with the hypothesis that insulin promotes the association of two alpha beta halves. Furthermore, the insulin-induced reoxidation reaction and the insulin-induced autophosphorylation show the same dose dependence ED50 3-4 x 10(-8) M insulin), suggesting that the noncovalent association of alpha beta half-receptors upon insulin binding is a prerequisite for insulin-stimulated autophosphorylation in concentrated alpha beta half-receptor preparations. If the alpha beta half-receptor forms are phosphorylated in the presence of an anti-phosphotyrosine antibody and separated from nonphosphorylated alpha beta receptors, we observed that the phosphorylated alpha beta receptor halves contain bound insulin. This excludes the possibility that alpha beta half-receptors that bind insulin, preferentially phosphorylate alpha beta halves that have no insulin bound.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834392

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors.

Authors:  J L Treadway; B D Morrison; M A Soos; K Siddle; J Olefsky; A Ullrich; D A McClain; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

2.  The alpha beta monomer of the insulin receptor has hormone-responsive tyrosine kinase activity.

Authors:  E R Mortensen; J G Drachman; G Guidotti
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

Review 3.  Insulin regulation of the Ras activation/inactivation cycle.

Authors:  B P Ceresa; J E Pessin
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

4.  Insulin receptor activation with transmembrane domain ligands.

Authors:  Jongsoon Lee; Masaya Miyazaki; Giulio R Romeo; Steven E Shoelson
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

5.  The endogenous functional turkey erythrocyte and rat liver insulin receptor is an alpha 2 beta 2 heterotetrameric complex.

Authors:  J L Treadway; B D Morrison; J A Wemmie; I Frias; T O'Hare; P F Pilch; J E Pessin
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

6.  Identification of the cysteine residues involved in the class I disulfide bonds of the human insulin receptor: properties of insulin receptor monomers.

Authors:  K Lu; G Guidotti
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

7.  A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization.

Authors:  O Kashles; Y Yarden; R Fischer; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Authors:  X Qian; C M LeVea; J K Freeman; W C Dougall; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor.

Authors:  R Levy-Toledano; L H Caro; D Accili; S I Taylor
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.